Bodhi Tree Biotechnology Inc (BDTB) Liabilities and Shareholders Equity (2024 - 2026)

Bodhi Tree Biotechnology (BDTB) has reported Liabilities and Shareholders Equity for 3 consecutive years, with $18323.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 85.89% year-over-year to $18323.0 in Q2 2026; TTM through Jun 2026 was $337045.0, a 38.7% decrease from a year earlier, with the FY2025 full-year figure at $119161.0, down 55.76% from the prior year.
• Liabilities and Shareholders Equity was $18323.0 for Q2 2026 at Bodhi Tree Biotechnology, down from $69713.0 in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $269327.0 in Q3 2024 and troughed at $18323.0 in Q2 2026.
• A 3-year average of $126165.7 and a median of $124504.5 in 2025 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity sank 55.76% in 2025 and tumbled 85.89% in 2026, its largest moves.
• Over 3 years, Liabilities and Shareholders Equity stood at $269327.0 in 2024, then sank by 74.12% to $69713.0 in 2025, then sank by 73.72% to $18323.0 in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $18323.0 (Q2 2026), $69713.0 (Q4 2025), and $119161.0 (Q3 2025), per Business Quant data.